This document describes the design and results of the validation exercise for the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay, organised by France and the United Kingdom. This method was developed for the detection of estrogen axis active substances. The project was on the Test Guidelines Programme work plan until 2024.
Forthcoming
Validation report for the Test Guideline 252 on the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay
OECD Series on Testing and Assessment
Will be released on:
